Apimeds Pharmaceuticals US bitcoin holdings
A pharmaceutical company on paper, a digital asset treasury platform in practice, with the coins held by a Dubai entity in segregated sub-wallets.
Key figures
- Bitcoin held
- 1,000 BTC
- As of
- 2026-08-13
- Rank
- 42 of 165
- Value at current price
- $63.2M
- Share of 21 million
- <0.01%
Holdings over time
Cumulative bitcoin held after each disclosed event. The line steps rather than slopes because treasury positions change on purchase dates, not continuously.
We have one dated figure for Apimeds Pharmaceuticals US so far, shown in the table below, and the table says where it came from. A chart needs at least two dated points, and we would rather show nothing than draw a trend through a single figure. This fills in as the company publishes, or as we backfill its earlier announcements.
Every disclosure we have
| Date | Event | Change | Total held | Note | Source |
|---|---|---|---|---|---|
| 2026-08-13 | Tracked | 1,000 | Tracker sync |
About Apimeds Pharmaceuticals US
The name is a leftover. Following a merger, Apimeds has focused its development on scaling an institutional digital asset treasury platform, and its balance sheet strategy is built to support that offering rather than a drug pipeline.
The custody arrangement is described in unusual detail for a company this size, and reading it is the point. The 1,000 coins are owned and controlled by TechyTrade (Dubai), free of encumbrances, identifiable and segregated inside a sub wallet architecture created and administered by MindWave Ltd for TechyTrade's benefit.
That is a longer chain than most entries here: the listed company, a Dubai subsidiary that owns the coins, and a third party that runs the wallet infrastructure. None of it is hidden, all of it is in the annual report, and anyone comparing this position against a company that simply holds coins with a qualified custodian should know the difference.
Compared with its neighbours
Sources
Holdings figures and their dates come from the disclosures linked in the history table above. Read the full methodology.